Rocuronium Fresenius rocuronium bromide 50mg/5mL solution for injection vial

Ülke: Avustralya

Dil: İngilizce

Kaynak: Department of Health (Therapeutic Goods Administration)

Aktif bileşen:

rocuronium bromide, Quantity: 10 g/L

Mevcut itibaren:

Fresenius Kabi Australia Pty Ltd

INN (International Adı):

Rocuronium bromide

Farmasötik formu:

Injection, solution

Kompozisyon:

Excipient Ingredients: water for injections; glacial acetic acid; sodium acetate trihydrate; sodium chloride

Uygulama yolu:

Intravenous

Paketteki üniteler:

10 x 5mL, 5 x 5mL

Reçete türü:

(S4) Prescription Only Medicine

Terapötik endikasyonlar:

INDICATIONS,Rocuronium is indicated as an adjunct to general anaesthesia to facilitate endotracheal intubation during routine induction, to provide muscle relaxation and to facilitate mechanical ventilation in adults, children and infants over 1 month of age.,Rocuronium is also indicated as an adjunct to general anaesthesia to facilitate endotracheal intubation during rapid sequence induction when suxamethonium is contraindicated, however, this has not been studied in infants and children.,Rocuronium is also indicated as an adjunct in the intensive care unit (ICU) to facilitate mechanical ventilation.

Ürün özeti:

Visual Identification: A clear, colourless to pale brownish-yellow solution.; Container Type: Vial; Container Material: Glass; Container Life Time: 24 Months; Container Temperature: Store at 2 to 8 degrees Celsius

Yetkilendirme durumu:

Licence status A

Yetkilendirme tarihi:

2014-11-12